These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14624052)

  • 1. Indices of thrombogenesis, endothelial damage and platelet function following percutaneous peripheral artery angiography and angioplasty for peripheral vascular disease.
    Makin AJ; Chung NA; Silverman SH; Moss MS; Lip GY
    Pathophysiol Haemost Thromb; 2003; 33(2):102-8. PubMed ID: 14624052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of thrombogenesis, endothelial damage and oxidative stress with reperfusion during femoral artery bypass surgery for peripheral vascular disease.
    Makin AJ; Chung NA; Silverman SH; Lip GY
    Pathophysiol Haemost Thromb; 2002; 32(4):158-64. PubMed ID: 12759516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity.
    Makin AJ; Chung NA; Silverman SH; Lip GY
    Thromb Res; 2003; 111(4-5):221-6. PubMed ID: 14693167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
    Goldsmith IR; Foo LS; Blann AD; Lip GY
    Clin Cardiol; 2000 Aug; 23(8):587-90. PubMed ID: 10941544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2002 Oct; 106(15):1962-7. PubMed ID: 12370220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease.
    Blann AD; Adams R; Ashleigh R; Naser S; Kirkpatrick U; McCollum CN
    Br J Radiol; 2001 Sep; 74(885):811-7. PubMed ID: 11560828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
    Bhatia GS; Sosin MD; Patel JV; Grindulis KA; Khattak FH; Davis RC; Lip GY
    Int J Cardiol; 2009 May; 134(1):97-103. PubMed ID: 18501982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
    Blann AD; Tan KT; Tayebjee MH; Davagnanam I; Moss M; Lip GY
    Thromb Haemost; 2005 Mar; 93(3):578-83. PubMed ID: 15735813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.
    Jaumdally RJ; Varma C; Blann AD; MacFadyen RJ; Lip GY
    Chest; 2007 Nov; 132(5):1532-9. PubMed ID: 17908707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
    Wilson AM; Brittenden J; Bachoo P; Ford I; Nixon GF
    J Vasc Surg; 2009 Oct; 50(4):861-9. PubMed ID: 19786240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.
    Boos CJ; Balakrishnan B; Jessani S; Blann AD; Lip GY
    Chest; 2007 Dec; 132(6):1920-6. PubMed ID: 18079225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation.
    Kornej J; Dinov B; Blann AD; Rolf S; Arya A; Schmidl J; Husser D; Hindricks G; Bollmann A; Lip GY
    PLoS One; 2014; 9(11):e111760. PubMed ID: 25390649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
    Roldán V; Marín F; García-Herola A; Lip GY
    Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.
    Genc H; Dogru T; Tapan S; Tasci I; Bozoglu E; Gok M; Aslan F; Celebi G; Erdem G; Avcu F; Ural AU; Sonmez A
    Clin Biochem; 2012 Jan; 45(1-2):92-5. PubMed ID: 22100896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.